Literature DB >> 6422918

Apoproteins B and A-I and coronary artery disease in humans.

J D Brunzell, A D Sniderman, J J Albers, P O Kwiterovich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6422918     DOI: 10.1161/01.atv.4.2.79

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


× No keyword cloud information.
  46 in total

Review 1.  Indications for lipid-lowering drugs.

Authors:  J Davignon
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Plasma apolipoproteins and risk for age related maculopathy.

Authors:  N Dashti; G McGwin; C Owsley; C A Curcio
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

3.  Serum lipoproteins in day and shift workers: a prospective study.

Authors:  A Knutson; H Andersson; U Berglund
Journal:  Br J Ind Med       Date:  1990-02

4.  Characterization of the promoter elements required for hepatic and intestinal transcription of the human apoB gene: definition of the DNA-binding site of a tissue-specific transcriptional factor.

Authors:  D Kardassis; M Hadzopoulou-Cladaras; D P Ramji; R Cortese; V I Zannis; C Cladaras
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

5.  Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region.

Authors:  E Boerwinkle; W J Xiong; E Fourest; L Chan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 6.  Genetic influences on susceptibility to atherosclerosis in the young.

Authors:  P O Kwiterovich
Journal:  Bull N Y Acad Med       Date:  1989-12

7.  Hepatocyte nuclear factor 1 and C/EBP are essential for the activity of the human apolipoprotein B gene second-intron enhancer.

Authors:  A R Brooks; B Levy-Wilson
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

Review 8.  Cholesterol and heart disease: current concepts in pathogenesis and treatment.

Authors:  L T Clark
Journal:  J Natl Med Assoc       Date:  1986-08       Impact factor: 1.798

9.  Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.

Authors:  J Q Purnell; S M Marcovina; J E Hokanson; H Kennedy; P A Cleary; M W Steffes; J D Brunzell
Journal:  Diabetes       Date:  1995-10       Impact factor: 9.461

10.  Genetic association study of selected candidate genes (ApoB, LPL, Leptin) and telomere length in obese and hypertensive individuals.

Authors:  Birajalaxmi Das; Nilambari Pawar; Divyalakshmi Saini; M Seshadri
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.